Literature DB >> 12576888

Survival after curative resection for mucinous adenocarcinoma of the colorectum.

Yukihide Kanemitsu1, Tomoyuki Kato, Takashi Hirai, Kenzo Yasui, Takeshi Morimoto, Yasuhiro Shimizu, Yasuhiro Kodera, Yoshitaka Yamamura.   

Abstract

PURPOSE: Previous reports have suggested that mucinous colorectal adenocarcinomas are more advanced at diagnosis and have a poorer prognosis than nonmucinous colorectal adenocarcinomas. The purpose of this study was to clarify whether the mucin-producing histologic type of carcinoma is associated with a worse prognosis than nonmucinous, differentiated colorectal adenocarcinoma for patients who undergo curative surgery.
METHODS: Using a database of 2,678 surgical patients with colorectal cancers operated on at Aichi Cancer Center between 1965 and 1994, we investigated 97 cases of mucinous adenocarcinoma and 2,197 cases of nonmucinous adenocarcinoma. We also evaluated the outcomes of patients who underwent surgery with curative intent. To determine whether the mucinous adenocarcinoma itself was an independent prognostic factor in the curative resected patients, a multivariate analysis was performed.
RESULTS: The mucinous adenocarcinoma patients were found to be younger (P = 0.0003), have more lymph node involvement (48.5 vs 40.3 percent; P = 0.0564), more peritoneal dissemination (19.6 vs 5.6 percent; P < 0.0001), greater frequency of advanced stage disease (P = 0.0006), a lower rate of curative resection (76.3 vs 84.4 percent; P = 0.0450), and lower overall 5-year survival rates (41 vs 62.4 percent; P = 0.0002) than nonmucinous adenocarcinoma patients. In the subjects who underwent curative resection, the 5-year survival rate for those with mucinous adenocarcinoma was significantly worse than for those with nonmucinous adenocarcinoma (54 vs 73.3 percent; P = 0.0020). Multivariate analysis using the Cox proportional hazards model showed that the clinically significant predictive factors were stage at diagnosis, mucinous histology, tumor location, gender and age. The mucinous histologic type itself was an independent factor for poor prognosis for patients who underwent curative surgery.
CONCLUSIONS: In patients with colorectal carcinomas who underwent surgery with curative intent and who had colorectal carcinomas of the mucinous histologic type, there was significant correlation with prognosis as measured by overall survival rate after adjustment had been made for major confounders.

Entities:  

Mesh:

Year:  2003        PMID: 12576888     DOI: 10.1007/s10350-004-6518-0

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  53 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.

Authors:  Charly Liddell; Laure Droy-Dupré; Sylvie Métairie; Fabrice Airaud; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Mod Pathol       Date:  2017-04-21       Impact factor: 7.842

3.  Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.

Authors:  John R Hyngstrom; Chung-Yuan Hu; Yan Xing; Y Nancy You; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Janice N Cormier; George J Chang
Journal:  Ann Surg Oncol       Date:  2012-04-04       Impact factor: 5.344

4.  Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.

Authors:  Vincenzo Catalano; Francesca Bergamo; Chiara Cremolini; Bruno Vincenzi; Francesca Negri; Paolo Giordani; Paolo Alessandroni; Rossana Intini; Silvia Stragliotto; Daniele Rossini; Beatrice Borelli; Daniele Santini; Donatella Sarti; Marco B L Rocchi; Sara Lonardi; Alfredo Falcone; Vittorina Zagonel; Rodolfo Mattioli; Francesco Graziano
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-06       Impact factor: 4.553

5.  Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.

Authors:  Soichiro Ishihara; Toshiaki Watanabe; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajime Shibuya; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Keiji Matsuda; Koutarou Maeda; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2011-11-04       Impact factor: 2.571

Review 6.  Mucinous carcinoma of the rectum: a distinct clinicopathological entity.

Authors:  M Chand; S Yu; R I Swift; G Brown
Journal:  Tech Coloproctol       Date:  2013-12-11       Impact factor: 3.781

7.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

8.  The Prognostic Implications of FIX and FLO Patterns in Mucinous Colon Carcinomas.

Authors:  Sulen Sarioglu; Guray Akturk; Selman Sokmen; Hulya Ellidokuz; Aras Emre Canda; Mehtat Unlu; Abdullah Haluk Sirin; Ozgul Sagol; Cem Terzi; Mehmet Fuzun
Journal:  J Gastrointest Cancer       Date:  2019-06

9.  The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.

Authors:  Benjamin D Powers; Seth I Felder; Iman Imanirad; Sophie Dessureault; Sean P Dineen
Journal:  J Gastrointest Cancer       Date:  2021-06

10.  Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.

Authors:  Masayasu Hara; Hayao Nakanishi; Qian Jun; Yukihide Kanemitsu; Seiji Ito; Yoshinari Mochizuki; Yoshitaka Yamamura; Yasuhiro Kodera; Masae Tatematsu; Takashi Hirai; Tomoyuki Kato
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.